Former Allergan CEO David Pyott Joins BioMarin Board

Date Posted:
Jan 4, 2016

San Rafael-based BioMarin Pharmaceutical Inc. have announced that David Pyott, the former Chairman and CEO of Allergan, will join the company board, effective immediately. Pyott oversaw the seven-fold growth in sales of Allergan products, including cosmetic drug Botox, between 1998 and 2015. His addition to the BioMarin board brings “expertise in organizational scaling [that will be] instrumental as we pursue the next significant stage of growth for the Company,” according to BioMarin Chairman and CEO Jean-Jacques Bienaimé.

For more information about David Pyott joining BioMarin, please visit the BioMarin website.